Denali Therapeutics reported revenue of $3.60M and net income of -$128.84M for the quarter ended Jun 2026. This income statement covers 38 quarters of results from Mar 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 122.01M | 122.28M | 122.86M | 123.16M | 123.80M | 135.97M | 136.74M | 137.36M | 138.05M | 138.39M | 142.51M | 143.12M | 143.84M | 144.22M | 145.25M | 145.69M | 146.63M | 156.18M | 158.66M | 159.76M | ||||||||||||||||||
| Revenue & cost | ||||||||||||||||||||||||||||||||||||||
| Revenue | 5.29M | 12.51M | 42.14M | 52.48M | 3.56M | 10.00M | 35.14M | 294.12M | 1.27M | 3.60M | ||||||||||||||||||||||||||||
| Gross Profit | 3.51M | |||||||||||||||||||||||||||||||||||||
| Operating items | ||||||||||||||||||||||||||||||||||||||
| Amortization - Intangibles | 0.75M | |||||||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 71.56M | 67.88M | 86.10M | 92.74M | 87.79M | 92.11M | 128.82M | 97.52M | 89.74M | 107.80M | 107.02M | 91.40M | 98.24M | 99.79M | 116.23M | 102.70M | 101.95M | 97.91M | 103.85M | 97.02M | ||||||||||||||||||
| Selling, General & AdministrativeSG&A | 19.32M | 21.76M | 22.54M | 21.16M | 23.26M | 23.52M | 27.14M | 26.12M | 25.32M | 24.77M | 25.24M | 25.19M | 24.95M | 30.06M | 29.35M | 32.27M | 35.48M | 39.46M | 33.51M | 36.28M | ||||||||||||||||||
| Other Operating ExpensesOther Opex | 14.54M | 0.84M | ||||||||||||||||||||||||||||||||||||
| Operating ExpensesOpex | 90.88M | 89.64M | 108.64M | 113.90M | 111.05M | 115.63M | 155.96M | 123.64M | 115.06M | 132.57M | 132.25M | 116.59M | 123.19M | 129.85M | 145.58M | 134.96M | 137.43M | 137.37M | 137.36M | 134.15M | ||||||||||||||||||
| Operating IncomeOp. Inc | -85.59M | -77.12M | -66.50M | -61.42M | -107.49M | -105.34M | -120.81M | 170.48M | -113.80M | -132.57M | -117.72M | -116.59M | -123.19M | -129.85M | -145.58M | -134.96M | -137.43M | -137.37M | -137.36M | -130.54M | ||||||||||||||||||
| EBIT | -85.59M | -77.12M | -66.50M | -61.42M | -107.49M | -105.34M | -120.81M | 170.48M | -113.80M | -132.57M | -117.72M | -116.59M | -123.19M | -129.85M | -145.58M | -134.96M | -137.43M | -137.37M | -137.36M | -130.54M | ||||||||||||||||||
| Non-operating items | ||||||||||||||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 11.03M | 12.90M | 14.44M | 13.13M | 15.91M | 17.57M | 15.99M | 15.16M | 12.61M | 10.84M | 10.53M | 8.92M | 8.91M | 2.99M | ||||||||||||||||||||||||
| Non Operating IncomeNon Op. Inc. | 1.00M | 1.28M | 1.28M | 2.65M | 4.19M | 6.66M | 11.03M | 12.90M | 14.44M | 13.13M | ||||||||||||||||||||||||||||
| Net income details | ||||||||||||||||||||||||||||||||||||||
| EBT | -84.59M | -75.84M | -66.50M | -58.77M | -103.30M | -98.68M | -109.78M | 183.38M | -99.35M | -119.44M | -101.80M | -99.03M | -107.19M | -114.69M | -132.97M | -124.12M | -126.90M | -128.45M | -128.45M | -127.55M | ||||||||||||||||||
| Tax ProvisionsTaxes | -0.57M | 0.03M | -0.01M | 0.03M | ||||||||||||||||||||||||||||||||||
| Profit After TaxPAT | -84.74M | -77.24M | -71.97M | -61.82M | -103.30M | -93.71M | -109.78M | 184.46M | -99.35M | -119.47M | -103.74M | -100.39M | -107.19M | -114.75M | -132.97M | -125.22M | -126.90M | -128.97M | -129.81M | -128.84M | ||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -84.59M | -75.26M | -66.50M | -58.79M | -103.30M | -98.68M | -109.78M | 183.38M | -99.35M | -119.47M | -101.80M | -99.03M | -107.19M | -114.69M | -132.97M | -124.12M | -126.90M | -128.45M | -128.45M | -127.55M | ||||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -84.59M | -75.26M | -66.50M | -58.79M | -103.30M | -98.68M | -109.78M | 183.38M | -99.35M | -119.47M | -101.80M | -99.03M | -107.19M | -114.69M | -132.97M | -124.12M | -126.90M | -128.45M | -128.45M | -127.55M | ||||||||||||||||||
| Income towards Parent CompanyParent Net Inc | -84.59M | -75.26M | -66.50M | -58.79M | -103.30M | -98.68M | -109.78M | 183.38M | -99.35M | -119.47M | -101.80M | -99.03M | -107.19M | -114.69M | -132.97M | -124.12M | -126.90M | -128.45M | -128.45M | -127.55M | ||||||||||||||||||
| Net Income towards Common StockholdersNet Income | -84.59M | -75.26M | -66.50M | -58.79M | -103.30M | -98.68M | -109.78M | 183.38M | -99.35M | -119.47M | -101.80M | -99.03M | -107.19M | -114.69M | -132.97M | -124.12M | -126.90M | -128.45M | -128.45M | -127.55M | ||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||||||||
| EPS (Basic) | -0.69 | -0.62 | -0.54 | -0.48 | -0.84 | -0.79 | -0.80 | 1.34 | -0.72 | -0.87 | -0.68 | -0.59 | -0.63 | -0.70 | -0.78 | -0.72 | -0.74 | -0.74 | -0.69 | -0.68 | ||||||||||||||||||
| EPS (Diluted) | -0.69 | -0.62 | -0.54 | -0.48 | -0.84 | -0.79 | -0.80 | 1.30 | -0.72 | -0.87 | -0.68 | -0.59 | -0.63 | -0.70 | -0.78 | -0.72 | -0.74 | -0.74 | -0.69 | -0.68 | ||||||||||||||||||
| Shares Outstanding | 121.74M | 121.52M | 122.67M | 123.01M | 123.47M | 125.53M | 136.52M | 137.05M | 137.64M | 137.37M | 149.40M | 168.83M | 169.46M | 164.47M | 171.22M | 171.45M | 172.42M | 172.65M | 186.64M | 187.31M | ||||||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 121.74M | 121.52M | 122.67M | 123.01M | 123.47M | 125.53M | 136.52M | 140.93M | 137.64M | 137.37M | 149.40M | 168.83M | 169.46M | 164.47M | 171.22M | 171.45M | 172.42M | 172.65M | 186.64M | 187.31M | ||||||||||||||||||
| EBITDA | -85.59M | -77.12M | -66.50M | -61.42M | -107.49M | -105.34M | -120.81M | 170.48M | -113.80M | -132.57M | -117.72M | -116.59M | -123.19M | -129.85M | -145.58M | -134.96M | -137.43M | -137.37M | -137.36M | -130.54M | ||||||||||||||||||
| Tax Rate | 0.76 | -0.05 | 0.01 | -0.03 |